HomeFHTX • NASDAQ
add
Foghorn Therapeutics Inc.
Previous close
$4.40
Day range
$4.11 - $4.48
Year range
$3.86 - $10.25
Market cap
246.83M USD
Avg Volume
146.32K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 2.86M | -50.49% |
Operating expense | -63.75M | 12.27% |
Net income | -19.50M | 19.09% |
Net profit margin | -682.88 | -63.43% |
Earnings per share | -0.30 | 47.37% |
EBITDA | -23.24M | 5.54% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 243.75M | 4.14% |
Total assets | 283.98M | -0.68% |
Total liabilities | 329.51M | -9.25% |
Total equity | -45.53M | — |
Shares outstanding | 55.61M | — |
Price to book | -5.37 | — |
Return on assets | -20.26% | — |
Return on capital | -5,030.39% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -19.50M | 19.09% |
Cash from operations | -24.52M | 10.97% |
Cash from investing | 22.29M | -40.37% |
Cash from financing | 4.00K | -97.85% |
Net change in cash | -2.22M | -122.17% |
Free cash flow | -4.39M | 30.77% |
About
Founded
2015
Website
Employees
112
